'Clearly a disappointing financial result': Why ASX 300 stock Austal just crashed 20%

This ASX 300 stock has sunk deep into the abyss on Wednesday. But why?

| More on:
A woman sits with her hands covering her eyes while lifting her spectacles sitting at a computer on a desk in an office setting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Austal Ltd (ASX: ASB) share price is having a day to forget on Wednesday.

The ASX 300 stock crashed as much as 22% to $2.01 in morning trade after returning from a trading halt.

The shipbuilder's shares have recovered a touch since then but remain down 11% to $2.20.

Why is the ASX 300 stock sinking?

Austal shares have taken a hit today after the company released an update on its earnings guidance.

According to the release, the company's US Towing, Salvage and Rescue Ship (T-ATS) program has been facing issues and has driven a substantial revision in its earnings guidance for FY 2023.

The ASX 300 stock notes that the T-ATS program has encountered changes in specification and general cost inflation pressures. In addition, the efficiency assumptions for the newly commissioned steel manufacturing line did not meet forecasts and have been subsequently revised.

And while these efficiency issues are expected to increasingly improve as Austal progresses construction of the T-ATS vessels, they are slowing progress on the first vessels in production.

Making things worse, the exercise of the option to construct the fifth and final vessel in the contract has also added in the associated cost issues to the onerous contract.

Austal USA has submitted requests for equitable adjustment (REAs) to seek recoveries for some of the additional costs incurred in the T-ATS project. However, the precise timing and success of those claims is uncertain. Any successful REA would benefit Austal's FY2024 results.

What's the damage?

The ASX 300 stock has advised that its earnings before interest and tax (EBIT) is now expected to be in the range of zero profit to a potential loss of $10 million. This compares to its previous guidance of EBIT of $58 million.

One positive, though, is that the company's balance sheet remains healthy. Its cash balance stood at $179 million at the end of June.

Austal's CEO, Paddy Gregg, blamed the poor financial performance on the sudden uptick in inflation and the timing of the contract award. He commented:

This is clearly a disappointing financial result for Austal given the success that we have had recently winning new projects to expand our US operations. The underlying issue is that the T-ATS award was received just prior to a period of unprecedented hyperinflation; some inaccurate assumptions were made regarding the efficiency of the new steel panel line in its first project' and the project has also been subject to specification changes from the original award.

It is clear that we need to make changes to some reporting structures and processes so that Austal USA can identify and rectify these sorts of issues in a more timely manner.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Austal. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
Healthcare Shares

3 ASX healthcare shares outperforming on quarterly updates

These stocks are charging ahead on an otherwise lacklustre trading day.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

ResMed share price jumps 10% on strong quarterly update

ResMed has impressed the market with its third-quarter update.

Read more »

Delighted adult man, working on a company slogan, on his laptop.
Earnings Results

Bank of Queensland share price leaps 6% on improving outlook

ASX 200 investors are bidding up the Bank of Queensland share price on Wednesday.

Read more »

Photo of two women shopping.
Earnings Results

Premier Investments share price jumps 9% on results and demerger plans

The Smiggle and Peter Alexander owner has released its results. How did it perform?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Earnings Results

Soul Patts share price struggles on falling profits

ASX 200 investment house Soul Patts reported its half year results this morning.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Brickworks share price tumbles on disappointing half-year loss

This loss didn't stop the company from increasing its dividend again.

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
Earnings Results

ASX All Ords stock KMD tumbles as interim dividend cancelled

Investors are hitting the sell button on ASX All Ords stock KMD today.

Read more »